世界のカボザンチニブ市場2020-2025:カプセル、錠剤

LP Informationが発行した調査報告書(LPI20OC0641)
◆英語タイトル:Global Cabozantinib Market Growth 2020-2025
◆商品コード:LPI20OC0641
◆発行会社(リサーチ会社):LP Information
◆発行日:2020年10月2日(※2023年版があります。お問い合わせください。)
◆ページ数:133
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
◆産業分野:Pharma & Healthcare
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,660 ⇒換算¥505,080見積依頼/購入/質問フォーム
Multi User(20名様閲覧用)USD5,490 ⇒換算¥757,620見積依頼/購入/質問フォーム
Corporate User(閲覧人数制限なし)USD7,320 ⇒換算¥1,010,160見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はLP Information社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。LP Information社の概要及び新刊レポートはこちらでご確認いただけます。

「カボザンチニブの世界市場」は、地域的には米州、アジア、欧州、中東・アフリカ市場をカバーしており、種類別には、カプセル、錠剤など、用途別には、自動車・航空宇宙、機器、石油・ガス、一般産業、その他などに区分してまとめた調査レポートです。カボザンチニブのグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が含まれています。
・カボザンチニブの世界市場概要(サマリー)
・カボザンチニブの企業別販売量・売上
・カボザンチニブの企業別市場シェア
・カボザンチニブの世界市場規模 2015年-2020年:種類別(カプセル、錠剤)
・カボザンチニブの世界市場規模 2015年-2020年:用途別(自動車・航空宇宙、機器、石油・ガス、一般産業、その他)
・カボザンチニブの米州市場規模(アメリカ、カナダ、メキシコなど)
・カボザンチニブのアジア市場規模(日本、中国、韓国、インド、東南アジアなど)
・カボザンチニブの欧州市場規模(ドイツ、フランス、イギリス、イタリア、ロシアなど)
・カボザンチニブの中東・アフリカ市場(エジプト、南アフリカ、トルコ、GCC諸国など)
・カボザンチニブ市場の成長要因・課題・動向
・カボザンチニブの世界市場予測 2021年-2025年
・カボザンチニブの米州市場予測(アメリカ、カナダ、メキシコなど)
・カボザンチニブのアジア市場予測(日本、中国、韓国、インド、東南アジアなど)
・カボザンチニブの欧州市場予測(ドイツ、フランス、イギリス、イタリア、ロシアなど)
・カボザンチニブの中東・アフリカ市場予測(エジプト、南アフリカ、トルコ、GCC諸国など)
・カボザンチニブの世界市場予測:種類別(カプセル、錠剤)
・カボザンチニブの世界市場予測:用途別(自動車・航空宇宙、機器、石油・ガス、一般産業、その他)
・主要企業分析
【レポートの概要】

According to this study, over the next five years the Cabozantinib market will register a xx%% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Cabozantinib business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Cabozantinib market by product type, application, key manufacturers and key regions and countries.

This study specially analyses the impact of Covid-19 outbreak on the Cabozantinib, covering the supply chain analysis, impact assessment to the Cabozantinib market size growth rate in several scenarios, and the measures to be undertaken by Cabozantinib companies in response to the COVID-19 epidemic.

Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.
Capsule
Tablet

Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.
Medullary Thyroid Cancer Treatment
Second Line Treatment for Renal Cell Carcinoma

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Exelixis
AlchemyPharm
Tecoland Corporation
Sun Pharmaceutical Industries Limit
MSN Laboratories Pvt Ltd
Fermion Oy
Huateng Pharmaceutical Co.
Shanghai Hope Chem
Bio Nova Pharmaceuticals Private Limited
Hetero Drugs Limited

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Cabozantinib consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of Cabozantinib market by identifying its various subsegments.
Focuses on the key global Cabozantinib manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Cabozantinib with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Cabozantinib submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

【レポートの目次】

1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Cabozantinib Consumption 2015-2025
2.1.2 Cabozantinib Consumption CAGR by Region
2.2 Cabozantinib Segment by Type
2.2.1 Capsule
2.2.2 Tablet
2.3 Cabozantinib Consumption by Type
2.3.1 Global Cabozantinib Consumption Market Share by Type (2015-2020)
2.3.2 Global Cabozantinib Revenue and Market Share by Type (2015-2020)
2.3.3 Global Cabozantinib Sale Price by Type (2015-2020)
2.4 Cabozantinib Segment by Application
2.4.1 Medullary Thyroid Cancer Treatment
2.4.2 Second Line Treatment for Renal Cell Carcinoma
2.5 Cabozantinib Consumption by Application
2.5.1 Global Cabozantinib Consumption Market Share by Type (2015-2020)
2.5.2 Global Cabozantinib Value and Market Share by Type (2015-2020)
2.5.3 Global Cabozantinib Sale Price by Type (2015-2020)

3 Global Cabozantinib by Company
3.1 Global Cabozantinib Sales Market Share by Company
3.1.1 Global Cabozantinib Sales by Company (2018-2020)
3.1.2 Global Cabozantinib Sales Market Share by Company (2018-2020)
3.2 Global Cabozantinib Revenue Market Share by Company
3.2.1 Global Cabozantinib Revenue by Company (2018-2020)
3.2.2 Global Cabozantinib Revenue Market Share by Company (2018-2020)
3.3 Global Cabozantinib Sale Price by Company
3.4 Global Cabozantinib Manufacturing Base Distribution, Sales Area, Type by Company
3.4.1 Global Cabozantinib Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players Cabozantinib Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Cabozantinib by Regions
4.1 Cabozantinib by Regions
4.2 Americas Cabozantinib Consumption Growth
4.3 APAC Cabozantinib Consumption Growth
4.4 Europe Cabozantinib Consumption Growth
4.5 Middle East & Africa Cabozantinib Consumption Growth

5 Americas
5.1 Americas Cabozantinib Consumption by Countries
5.1.1 Americas Cabozantinib Consumption by Countries (2015-2020)
5.1.2 Americas Cabozantinib Value by Countries (2015-2020)
5.2 Americas Cabozantinib Consumption by Type
5.3 Americas Cabozantinib Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries

6 APAC
6.1 APAC Cabozantinib Consumption by Regions
6.1.1 APAC Cabozantinib Consumption by Regions (2015-2020)
6.1.2 APAC Cabozantinib Value by Regions (2015-2020)
6.2 APAC Cabozantinib Consumption by Type
6.3 APAC Cabozantinib Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions

7 Europe
7.1 Europe Cabozantinib by Countries
7.1.1 Europe Cabozantinib Consumption by Countries (2015-2020)
7.1.2 Europe Cabozantinib Value by Countries (2015-2020)
7.2 Europe Cabozantinib Consumption by Type
7.3 Europe Cabozantinib Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa
8.1 Middle East & Africa Cabozantinib by Countries
8.1.1 Middle East & Africa Cabozantinib Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa Cabozantinib Value by Countries (2015-2020)
8.2 Middle East & Africa Cabozantinib Consumption by Type
8.3 Middle East & Africa Cabozantinib Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Cabozantinib Distributors
10.3 Cabozantinib Customer

11 Global Cabozantinib Market Forecast
11.1 Global Cabozantinib Consumption Forecast (2021-2025)
11.2 Global Cabozantinib Forecast by Regions
11.2.1 Global Cabozantinib Forecast by Regions (2021-2025)
11.2.2 Global Cabozantinib Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Cabozantinib Forecast by Type
11.8 Global Cabozantinib Forecast by Application

12 Key Players Analysis
12.1 Exelixis
12.1.1 Company Information
12.1.2 Cabozantinib Product Offered
12.1.3 Exelixis Cabozantinib Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 Exelixis Latest Developments
12.2 AlchemyPharm
12.2.1 Company Information
12.2.2 Cabozantinib Product Offered
12.2.3 AlchemyPharm Cabozantinib Sales, Revenue, Price and Gross Margin (2018-2020)
12.2.4 Main Business Overview
12.2.5 AlchemyPharm Latest Developments
12.3 Tecoland Corporation
12.3.1 Company Information
12.3.2 Cabozantinib Product Offered
12.3.3 Tecoland Corporation Cabozantinib Sales, Revenue, Price and Gross Margin (2018-2020)
12.3.4 Main Business Overview
12.3.5 Tecoland Corporation Latest Developments
12.4 Sun Pharmaceutical Industries Limit
12.4.1 Company Information
12.4.2 Cabozantinib Product Offered
12.4.3 Sun Pharmaceutical Industries Limit Cabozantinib Sales, Revenue, Price and Gross Margin (2018-2020)
12.4.4 Main Business Overview
12.4.5 Sun Pharmaceutical Industries Limit Latest Developments
12.5 MSN Laboratories Pvt Ltd
12.5.1 Company Information
12.5.2 Cabozantinib Product Offered
12.5.3 MSN Laboratories Pvt Ltd Cabozantinib Sales, Revenue, Price and Gross Margin (2018-2020)
12.5.4 Main Business Overview
12.5.5 MSN Laboratories Pvt Ltd Latest Developments
12.6 Fermion Oy
12.6.1 Company Information
12.6.2 Cabozantinib Product Offered
12.6.3 Fermion Oy Cabozantinib Sales, Revenue, Price and Gross Margin (2018-2020)
12.6.4 Main Business Overview
12.6.5 Fermion Oy Latest Developments
12.7 Huateng Pharmaceutical Co.
12.7.1 Company Information
12.7.2 Cabozantinib Product Offered
12.7.3 Huateng Pharmaceutical Co. Cabozantinib Sales, Revenue, Price and Gross Margin (2018-2020)
12.7.4 Main Business Overview
12.7.5 Huateng Pharmaceutical Co. Latest Developments
12.8 Shanghai Hope Chem
12.8.1 Company Information
12.8.2 Cabozantinib Product Offered
12.8.3 Shanghai Hope Chem Cabozantinib Sales, Revenue, Price and Gross Margin (2018-2020)
12.8.4 Main Business Overview
12.8.5 Shanghai Hope Chem Latest Developments
12.9 Bio Nova Pharmaceuticals Private Limited
12.9.1 Company Information
12.9.2 Cabozantinib Product Offered
12.9.3 Bio Nova Pharmaceuticals Private Limited Cabozantinib Sales, Revenue, Price and Gross Margin (2018-2020)
12.9.4 Main Business Overview
12.9.5 Bio Nova Pharmaceuticals Private Limited Latest Developments
12.10 Hetero Drugs Limited
12.10.1 Company Information
12.10.2 Cabozantinib Product Offered
12.10.3 Hetero Drugs Limited Cabozantinib Sales, Revenue, Price and Gross Margin (2018-2020)
12.10.4 Main Business Overview
12.10.5 Hetero Drugs Limited Latest Developments

13 Research Findings and Conclusion

...

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界のカボザンチニブ市場2020-2025:カプセル、錠剤(Global Cabozantinib Market Growth 2020-2025)]についてメールでお問い合わせはこちらでお願いします。